German pharmaceutical company Stada plans a multi-billion-euro IPO in Frankfurt this autumn to reduce debt and provide an exit for its private equity owners.
German pharmaceutical company Stada plans a multi-billion-euro IPO in Frankfurt this autumn to reduce debt and provide an exit for its private equity owners.